PET Imaging Using 64Cu-Tz-SarAr and hu5B1-TCO in People With Pancreatic, Colorectal, Bladder Cancer or Cancers With Elevated CA19.9

NCT05737615 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study tracer is currently unavailable

Conditions

Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma
Metastatic Pancreatic Ductal Adenocarcinoma
Primary Pancreatic Ductal Adenocarcinoma
Metastatic Pancreatic Cancer

Interventions

DIAGNOSTIC_TEST: PET Scan
DRUG: hu5B1-TCO
DRUG: 64Cu-Tz-SarAr
DIAGNOSTIC_TEST: Pharmacokinetics

Sponsor

Memorial Sloan Kettering Cancer Center